forum zespołu muzyki folk Portfolk
Zapraszamy do dyskusji... TO SCOTLAND!!!
FAQ
Szukaj
Użytkownicy
Grupy
Galerie
Rejestracja
Profil
Zaloguj się, by sprawdzić wiadomości
Zaloguj
Forum forum zespołu muzyki folk Portfolk Strona Główna
->
Koncerty
Napisz odpowiedź
Użytkownik
Temat
Treść wiadomości
Emotikony
Więcej Ikon
Kolor:
Domyślny
Ciemnoczerwony
Czerwony
Pomarańćzowy
Brązowy
Żółty
Zielony
Oliwkowy
Błękitny
Niebieski
Ciemnoniebieski
Purpurowy
Fioletowy
Biały
Czarny
Rozmiar:
Minimalny
Mały
Normalny
Duży
Ogromny
Zamknij Tagi
Opcje
HTML:
NIE
BBCode
:
TAK
Uśmieszki:
TAK
Wyłącz BBCode w tym poście
Wyłącz Uśmieszki w tym poście
Kod potwierdzający: *
Wszystkie czasy w strefie EET (Europa)
Skocz do:
Wybierz forum
KATEGORIE
----------------
Koncerty
Doradź nam coś.
Co o nas myślisz?
O wszystkim i o niczym
Przegląd tematu
Autor
Wiadomość
cheapbag214s
Wysłany: Czw 3:16, 28 Lis 2013
Temat postu: the report said. Moreover
Report: Lack of antibiotics for superbugs in development
WASHINGTON, April 18 () -- The current pipeline of antibiotics is fragile and the dwindling roster of antibiotic developers has dire consequences for public health, U.S. experts say. Dr. Henry Chambers, chairman of Infectious Diseases Society of America's Antimicrobial Resistance Committee, said at this urgent time of greatest need, the number of pharmaceutical companies investing in antibiotic research and development plummeted.In a report, published online in the Clinical Infectious Diseases, IDSA identified only seven new drugs in development for the treatment of infections caused by multi-drug-resistant gram-negative bacilli bacteria -- superbugs. Pharmaceutical companies typically put research and development resources into the development of chronic disease drugs -- including those to treat high cholesterol, diabetes and cancer -- which provide significant financial rewards, partly because they are intended to be taken for long periods of time, Chambers said. Antibiotics, which are intended to be taken for short period of time, can't compete, Chambers said. The results are playing out in real time, with a smaller pharmaceutical company, Polymedix,[url=http://www.christianlouboutinonlineshop.de/]christian louboutin schuhe[/url], which has one of the seven drugs in development, filing for bankruptcy protection in early April 2013, the report said. Moreover, the policy update reports only four large multi-national companies remain in antibiotic research and development. One of these,[url=http://www.isabelmarantsneakersbootss.com/]isabel marant sneakers[/url], AstraZeneca, which has two of the seven drugs in development, plans to reduce its future investments in antibiotics, Pascal Soriot, it's chief executive officer said recently. The IDSA first warned of the looming antibiotic apocalypse with its 2004 report, "Bad Bugs, No Drugs."
fora.pl
- załóż własne forum dyskusyjne za darmo
Powered by
phpBB
© 2001 phpBB Group
Chronicles phpBB2 theme by
Jakob Persson
(
http://www.eddingschronicles.com
). Stone textures by
Patty Herford
.
Regulamin